Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.
Clinical trial NCT00828958 · COMPLETED
Trial details
- NCT number
- NCT00828958
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.